Valuation Harbin Gloria Pharmaceuticals Co., Ltd

Stocks

End-of-day quote Shenzhen S.E. 2026-10-21			5-day change	1st Jan Change
3.240 ^CNY	+2.21%		-1.82%	+5.54%

08-26	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2026	CI
04-27	HARBIN GLORIA PHARMACEUTICALS Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	7,034	6,397	5,583	5,517	5,677	6,852
Change	-	-9.06%	-12.71%	-1.18%	2.89%	20.71%
Enterprise Value (EV) ¹	7,491	6,459	5,750	5,482	5,168	6,014
Change	-	-13.78%	-10.98%	-4.66%	-5.72%	16.38%
P/E	17.6x	142x	-19.2x	45.9x	24.2x	18.2x
PBR	3.81x	3.38x	3.42x	3.32x	2.91x	2.99x
PEG	-	-1.6x	0x	-0x	0.3x	0.3x
Capitalization / Revenue	2.3x	2.03x	1.8x	2.1x	2.33x	3.21x
EV / Revenue	2.45x	2.05x	1.85x	2.09x	2.12x	2.82x
EV / EBITDA	4,078x	25.5x	26.8x	19.9x	16.4x	18.8x
EV / EBIT	-51.8x	55.8x	67.2x	31.9x	22.9x	26.1x
EV / FCF	66.4x	24.8x	112x	54.4x	14.7x	76.8x
FCF Yield	1.51%	4.03%	0.89%	1.84%	6.8%	1.3%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.182	0.0205	-0.1325	0.0547	0.1029	0.1686
Distribution rate	-	-	-	-	-	-
Net sales ¹	3,055	3,145	3,108	2,626	2,441	2,135
EBITDA ¹	1.837	253.2	214.5	275.5	315.9	319.7
EBIT ¹	-144.7	115.7	85.61	172	225.3	230.8
Net income ¹	400	45.04	-291.3	120.3	232.8	376.9
Net Debt ¹	457	62.42	166.7	-35.59	-508.7	-838.1
Reference price ²	3.200	2.910	2.540	2.510	2.490	3.070
Nbr of stocks (in thousands)	2,198,123	2,198,123	2,198,123	2,198,123	2,279,750	2,232,028
Announcement Date	4/28/21	4/25/22	4/23/23	4/19/24	4/25/25	4/27/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
HARBIN GLORIA PHARMACEUTICALS CO., LTD	-	-	-	-	1.08B
ELI LILLY AND COMPANY	36.67x	13.07x	27.74x	0.54%	1,133B
JOHNSON & JOHNSON	37.73x	6.36x	17.89x	2.07%	621B
ABBVIE INC.	36.35x	8.36x	17.26x	2.41%	503B
ROCHE HOLDING AG	21.21x	5.12x	12.74x	2.55%	379B
MERCK & CO., INC.	109.25x	6.09x	26.14x	2.27%	370B
NOVARTIS AG	21.57x	5.62x	13.82x	2.84%	292B
ASTRAZENECA PLC	22.08x	4.46x	12.77x	1.98%	262B
AMGEN INC.	27.83x	7.14x	12.79x	2.3%	237B
GILEAD SCIENCES, INC.	-44.76x	6.88x	26.67x	2.15%	190B
Average	29.77x	7.01x	18.64x	2.12%	398.91B
Weighted average by Cap.	35.57x	8.27x	20.36x	1.81%